| PTO Form 1963 (Rev 5/2006) |
| OMB No. 0651-0055 (Exp 07/31/2018) |
Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9
The table below presents the data as entered.
Input Field
|
Entered
|
| REGISTRATION NUMBER |
2618835 |
| REGISTRATION DATE |
09/10/2002 |
| SERIAL NUMBER |
76173227 |
| MARK SECTION |
| MARK |
REMODULIN |
| ATTORNEY SECTION (current) |
| NAME |
Andrew Fisher |
| FIRM NAME |
UNITED THERAPEUTICS CORPORATION |
| STREET |
1735 CONNECTICUT AVE NW FL 3 |
| CITY |
WASHINGTON |
| STATE |
District of Columbia |
| POSTAL CODE |
20009-1108 |
| COUNTRY |
United States |
| EMAIL |
andy@unither.com |
| AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
| ATTORNEY SECTION (proposed) |
| NAME |
Norm J. Rich |
| FIRM NAME |
Foley & Lardner LLP |
| INTERNAL ADDRESS |
Sixth Floor |
| STREET |
3000 K Street, N.W. |
| CITY |
WASHINGTON |
| STATE |
District of Columbia |
| POSTAL CODE |
20007-5109 |
| COUNTRY |
United States |
| PHONE |
202-672-5300 |
| FAX |
202-672-5399 |
| EMAIL |
PTOMAILWashington@foley.com |
| AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
| DOCKET/REFERENCE NUMBER |
808618-0793 |
| OTHER APPOINTED ATTORNEY |
all other attorneys of Foley & Lardner LLP |
| CORRESPONDENCE SECTION (current) |
| NAME |
ANDREW FISHER |
| FIRM NAME |
UNITED THERAPEUTICS CORPORATION |
| STREET |
1735 CONNECTICUT AVE NW FL 3 |
| CITY |
WASHINGTON |
| STATE |
District of Columbia |
| POSTAL CODE |
20009-1108 |
| COUNTRY |
United States |
| EMAIL |
andy@unither.com |
| AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
| CORRESPONDENCE SECTION (proposed) |
| NAME |
Norm J. Rich |
| FIRM NAME |
Foley & Lardner LLP |
| INTERNAL ADDRESS |
Sixth Floor |
| STREET |
3000 K Street, N.W. |
| CITY |
WASHINGTON |
| STATE |
District of Columbia |
| POSTAL CODE |
20007-5109 |
| COUNTRY |
United States |
| PHONE |
202-672-5300 |
| FAX |
202-672-5399 |
| EMAIL |
PTOMAILWashington@foley.com |
| AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
| DOCKET/REFERENCE NUMBER |
808618-0793 |
| GOODS AND/OR SERVICES SECTION |
| INTERNATIONAL CLASS |
005 |
| GOODS OR SERVICES |
pharmaceutical preparation used in the treatment of cardiovascular, pulmonary, and vascular diseases; A pharmaceutical preparation used in the
treatment of cardiopulmonary and cardiovascular diseases |
| SPECIMEN FILE NAME(S) |
| ORIGINAL PDF FILE |
SPN0-20487401-115437420_._CLASS5SPEC.pdf |
CONVERTED PDF FILE(S)
(2 pages) |
\\TICRS\EXPORT16\IMAGEOUT16\761\732\76173227\xml1\S890002.JPG |
| |
\\TICRS\EXPORT16\IMAGEOUT16\761\732\76173227\xml1\S890003.JPG |
| SPECIMEN DESCRIPTION |
an excerpt from the package insert included in all packaging for the drug product, Remodulin |
| OWNER SECTION (current) |
| NAME |
United Therapeutics Corporation |
| STREET |
1110 Spring Street |
| CITY |
Silver Spring |
| STATE |
Maryland |
| ZIP/POSTAL CODE |
20910 |
| COUNTRY |
United States |
| LEGAL ENTITY SECTION (current) |
| TYPE |
corporation |
| STATE/COUNTRY OF INCORPORATION |
Delaware |
| PAYMENT SECTION |
| NUMBER OF CLASSES |
1 |
| NUMBER OF CLASSES PAID |
1 |
| SUBTOTAL AMOUNT |
500 |
| TOTAL FEE PAID |
500 |
| SIGNATURE SECTION |
| SIGNATURE |
/Andrew Fisher/ |
| SIGNATORY'S NAME |
Andrew Fisher |
| SIGNATORY'S POSITION |
Chief Strategic Officer |
| DATE SIGNED |
09/06/2012 |
| SIGNATORY'S PHONE NUMBER |
202-483-7000 |
| PAYMENT METHOD |
CC |
| FILING INFORMATION |
| SUBMIT DATE |
Thu Sep 06 10:23:56 EDT 2012 |
| TEAS STAMP |
USPTO/S08N09-XXX.XX.XX.X-
20120906102356045681-2618
835-4902d291ff2bd114ef6bf
14d7c1313caa-CC-11782-201
20905132235091431 |
| PTO Form 1963 (Rev 5/2006) |
| OMB No. 0651-0055 (Exp 07/31/2018) |
Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9
To the Commissioner for Trademarks:
REGISTRATION NUMBER: 2618835
REGISTRATION DATE: 09/10/2002
MARK: REMODULIN
The owner, United Therapeutics Corporation, a corporation of Delaware, having an address of
1110 Spring Street
Silver Spring, Maryland 20910
United States
is filing a Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9.
For International Class 005, the mark is in use in commerce on or in connection with
all goods/services, or to indicate membership in the collective membership organization, listed in the
existing registration for this specific class: pharmaceutical preparation used in the treatment of cardiovascular, pulmonary, and vascular diseases; A pharmaceutical preparation used in the treatment
of cardiopulmonary and cardiovascular diseases ; or, the owner is making the listed excusable nonuse claim.
The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) an excerpt from the package insert included
in all packaging for the drug product, Remodulin.
Original PDF file:
SPN0-20487401-115437420_._CLASS5SPEC.pdf
Converted PDF file(s) (2 pages)
Specimen File1
Specimen File2
The registrant's current Attorney Information: Andrew Fisher of UNITED THERAPEUTICS CORPORATION
1735 CONNECTICUT AVE NW FL 3
WASHINGTON, District of Columbia (DC) 20009-1108
United States
The registrant's proposed Attorney Information: Norm J. Rich of Foley & Lardner LLP
Sixth Floor
3000 K Street, N.W.
WASHINGTON, District of Columbia (DC) 20007-5109
United States
The docket/reference number is 808618-0793.
The Other Appointed Attorney(s): all other attorneys of Foley & Lardner LLP.
The phone number is 202-672-5300.
The fax number is 202-672-5399.
The email address is PTOMAILWashington@foley.com.
The registrant's current Correspondence Information: ANDREW FISHER of UNITED THERAPEUTICS CORPORATION
1735 CONNECTICUT AVE NW FL 3
WASHINGTON, District of Columbia (DC) 20009-1108
United States
The registrant's proposed Correspondence Information: Norm J. Rich of Foley & Lardner LLP
Sixth Floor
3000 K Street, N.W.
WASHINGTON, District of Columbia (DC) 20007-5109
United States
The docket/reference number is 808618-0793.
The phone number is 202-672-5300.
The fax number is 202-672-5399.
The email address is PTOMAILWashington@foley.com.
A fee payment in the amount of $500 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.
Declaration
Section 8: Declaration of Use and/or Excusable Nonuse in Commerce
Unless the owner has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods and/or services identified above, as evidenced by the attached
specimen(s) showing the mark as used in commerce.
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Section 9: Application for Renewal
The registrant requests that the registration be renewed for the goods/services/collective organization identified above.
Signature: /Andrew Fisher/ Date: 09/06/2012
Signatory's Name: Andrew Fisher
Signatory's Position: Chief Strategic Officer
Signatory's Phone Number: 202-483-7000
Mailing Address
(current):
UNITED THERAPEUTICS CORPORATION
1735 CONNECTICUT AVE NW FL 3
WASHINGTON, District of Columbia 20009-1108
Mailing Address
(proposed):
Foley & Lardner LLP
3000 K Street, N.W.
WASHINGTON, District of Columbia 20007-5109
Serial Number: 76173227
Internet Transmission Date: Thu Sep 06 10:23:56 EDT 2012
TEAS Stamp: USPTO/S08N09-XXX.XX.XX.X-201209061023560
45681-2618835-4902d291ff2bd114ef6bf14d7c
1313caa-CC-11782-20120905132235091431
